A new strategy for the preparation of heterocyclic β-amino esters: orthogonally protected β-amino esters with a piperidine skeleton
暂无分享,去创建一个
[1] F. Fülöp,et al. Diastereo- and Enantioselective Synthesis of Orthogonally Protected 2,4-Diaminocyclopentanecarboxylates: A Flip from β-Amino- to β,γ-Diaminocarboxylates , 2007 .
[2] C. Corvaja,et al. Synthesis of Enantiomerically Pure cis‐ and trans‐4‐Amino‐1‐oxyl‐2,2,6,6‐tetramethylpiperidine‐3‐carboxylic Acid: A Spin‐Labelled, Cyclic, Chiral β‐Amino Acid, and 3D‐Structural Analysis of a Doubly Spin‐Labelled β‐Hexapeptide , 2007 .
[3] Andrew H. Gordon,et al. Glycosylated foldamers to probe the carbohydrate-carbohydrate interaction. , 2006, Journal of the American Chemical Society.
[4] F. Fülöp,et al. Application of alicyclic β-amino acids in peptide chemistry , 2006 .
[5] J. Esko,et al. Synthesis and biological evaluation of gem-diamine 1-N-iminosugars related to L-iduronic acid as inhibitors of heparan sulfate 2-O-sulfotransferase. , 2006, Bioorganic & medicinal chemistry letters.
[6] F. Fülöp,et al. Syntheses of Hydroxylated Cyclic β-Amino Acid Derivatives , 2005 .
[7] S. Gellman,et al. Use of parallel synthesis to probe structure-activity relationships among 12-helical beta-peptides: evidence of a limit on antimicrobial activity. , 2005, Journal of the American Chemical Society.
[8] S. Davies,et al. Cyclic beta-amino acid derivatives: synthesis via lithium amide promoted tandem asymmetric conjugate addition-cyclisation reactions. , 2005, Organic & biomolecular chemistry.
[9] F. Fülöp,et al. Advanced procedure for the enzymatic ring opening of unsaturated alicyclic β-lactams , 2004 .
[10] Ferenc Fülöp,et al. Side-chain control of beta-peptide secondary structures. , 2003, European journal of biochemistry.
[11] G. Morgant,et al. Synthetic approaches to Cinchona alkaloids: the C-8/C-9 disconnection strategy , 2003 .
[12] C. Toniolo,et al. 4-Amino-1-oxyl-2,2,6,6-tetramethylpiperidine-3-carboxylic acid (β-TOAC), the first spin-labelled, cyclic, chiral β-amino acid resolved in an enantiomerically pure state , 2003 .
[13] S. Gellman,et al. Asymmetric Synthesis of a New Helix‐Forming β‐Amino Acid: trans‐4‐Aminopiperidine‐3‐carboxylic Acid , 2003 .
[14] S. Gellman,et al. Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides , 2002 .
[15] C. Trapella,et al. A new synthetic approach to 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one(J-113397), the first non-peptide ORL-1 receptor antagonist.. , 2001, Bioorganic & medicinal chemistry.
[16] F. Fülöp,et al. The chemistry of 2-aminocycloalkanecarboxylic acids. , 2001, Chemical reviews.
[17] W G Laver,et al. Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. , 2001, Journal of medicinal chemistry.
[18] S. Gellman,et al. Antibiotics: Non-haemolytic β-amino-acid oligomers , 2000, Nature.
[19] Y. Iwasawa,et al. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397). , 1999, Journal of medicinal chemistry.
[20] T. Takeuchi,et al. Synthesis and antimetastatic activity of L-iduronic acid-type 1-N-iminosugars. , 1997, Journal of medicinal chemistry.
[21] E. Juaristi. Enantioselective synthesis of β-amino acids , 1997 .
[22] T. Takeuchi,et al. The First l-Iduronic Acid-Type 1-N-Iminosugars Having Inhibitory Activity of Experimental Metastasis , 1996 .